SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Applying health economics for policy decision making: do devices differ from drugs?
7 references·3 citing·35 second hop
Applying health economics for policy decision making: do devices differ from drugs? (2011)Applying health economics for policy deci…Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Key principles for the improv…Economic Evaluation for Devices and Drugs—Same or Different? (2008)Economic Evaluation for Devic…Methods for the economic evaluation of health care programmes, 3rd ed (2006)Methods for the economic eval…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle (2004)Inclusion of cost effectivene…Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction (2001)Potential Cost-Effectiveness …Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE (2018)HEALTH TECHNOLOGY ASSESSMENT …Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review (2017)Existing reporting guidelines…Health technology assessment of medical devices: What is different? An overview of three European projects (2015)Health technology assessment …Statistical assessment of the learning curves of health technologies (2001)Comparative Effectiveness Research: A Report From the Institute of Medicine (2009)IDEAL framework for surgical innovation 1: the idea and development stages (2013)Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices (2019)Combination of direct and indirect evidence in mixed treatment comparisons (2004)Medical technology procurement in Europe: A cross-country comparison of current practice and policy (2010)The Economic Burden of Complications Occurring in Major Surgical Procedures: a Systematic Review (2013)Challenges in the Assessment of Medical Devices: The MedtecHTA Project (2017)Markov Models in Medical Decision Making (1993)Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Cost-effectiveness as an outcome in randomized clinical trials (2006)Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)Health Economic Guidelines—Similarities, Differences and Some Implications (2001)Theory versuspractice: a review of ?willingness-to-pay? in health and health care (2001)Measuring Preferences for Cost-Utility Analysis (2007)Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions (2012)Comparing the ICERs in Medicine Reimbursement Submissions to NICE and PBAC—Does the Presence of an Explicit Threshold Affect the ICER Proposed? (2018)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)Quality of reporting in randomized controlled trials of therapeutic cardiovascular medical devices (2018)The Delphi method as a research tool: an example, design considerations and applications (2004)The Delphi technique (2005)The Delphi Technique: Making Sense of Consensus (2020)Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies (2021)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Conducting Discrete Choice Experiments to Inform Healthcare Decision Making (2008)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2006Methods for the economic evaluation of health care programmes, 3rd ed956 cited
  • 2008Key principles for the improved conduct of health technology assessments for resource allocation decisions489 cited
  • 2008Economic Evaluation for Devices and Drugs—Same or Different?237 cited
  • 2004Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle194 cited
  • 2001Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction79 cited

Cited by

  • 2015Health technology assessment of medical devices: What is different? An overview of three European projects51 cited
  • 2018HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE50 cited
  • 2017Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review5 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work